Table 1 Baseline characteristics of participants in the NHANES 2017ā2020.3 cycle.
Characteristic | eGDR (mg/kg/min) | P value | |||
|---|---|---|---|---|---|
Q1(<ā5.271) | Q2(5.271ā7.692) | Q3(7.692ā9.837) | Q4(ā„ā9.837) | ||
Age (year) | 57.24(0.78) | 53.76(1.07) | 46.93(0.94) | 38.35(0.87) | ā<ā0.0001 |
Sex, n (%) | Ā | Ā | Ā | Ā | ā<ā0.001 |
Ā Female | 430(45.00) | 455(51.86) | 460(49.59) | 553(60.86) | Ā |
Ā Male | 468(55.00) | 440(48.14) | 435(50.41) | 344(39.14) | Ā |
Race, n (%) | Ā | Ā | Ā | Ā | 0.002 |
Ā Non-hispanic black | 296(12.74) | 239(12.15) | 176(8.93) | 197(9.37) | Ā |
Ā Mexican race | 67(4.70) | 77(6.09) | 124(8.68) | 90(6.85) | Ā |
Ā Other race | 163(11.67) | 258(17.61) | 268(15.92) | 313(18.54) | Ā |
Ā Non-hispanic white | 372(70.89) | 321(64.15) | 327(66.48) | 297(65.24) | Ā |
Education level, n (%) | Ā | Ā | Ā | Ā | 0.001 |
Ā High school | 224(28.63) | 191(25.53) | 176(21.64) | 173(19.76) | Ā |
Ā Less than high school | 130(9.04) | 129(8.89) | 121(7.57) | 97(5.03) | Ā |
Ā More than high school | 544(62.33) | 575(65.58) | 598(70.80) | 627(75.21) | Ā |
Marital status, n (%) | Ā | Ā | Ā | Ā | 0.02 |
Ā Married or cohabitation | 534(69.25) | 547(66.29) | 583(66.66) | 533(58.90) | Ā |
Ā Others | 364(30.75) | 348(33.71) | 312(33.34) | 364(41.10) | Ā |
PIR, n (%) | Ā | Ā | Ā | Ā | 0.63 |
Ā <ā1.0 | 138(8.44) | 126(9.64) | 127(8.61) | 143(10.40) | Ā |
Ā 1.0ā3.0 | 368(31.91) | 372(32.00) | 341(29.61) | 328(27.92) | Ā |
Ā ā„ā3.0 | 392(59.65) | 397(58.36) | 427(61.78) | 426(61.68) | Ā |
BMI, Kg/m2 | 35.95(0.37) | 30.52(0.33) | 29.96(0.22) | 23.53(0.14) | ā<ā0.0001 |
HbA1c (%) | 6.35(0.08) | 5.72(0.04) | 5.51(0.02) | 5.24(0.01) | ā<ā0.0001 |
Hypertension, n (%) | Ā | Ā | Ā | Ā | ā<ā0.0001 |
Ā No | 41(4.35) | 247(32.44) | 855(97.00) | 897(100.00) | Ā |
Ā Yes | 857(95.65) | 648(67.56) | 40(3.00) | 0(0.00) | Ā |
Diabetes, n (%) | Ā | Ā | Ā | Ā | ā<ā0.0001 |
Ā DM | 417(42.85) | 170(14.77) | 88(6.03) | 15(0.64) | Ā |
Ā IFG | 74(10.33) | 82(9.78) | 63(7.81) | 31(2.49) | Ā |
Ā No | 407(46.83) | 643(75.45) | 744(86.16) | 851(96.87) | Ā |
Hyperlipidemia, n (%) | Ā | Ā | Ā | Ā | ā<ā0.0001 |
Ā No | 162(15.89) | 204(22.67) | 267(28.75) | 508(56.95) | Ā |
Ā Yes | 736(84.11) | 691(77.33) | 628(71.25) | 389(43.05) | Ā |
Smoking, n (%) | Ā | Ā | Ā | Ā | 0.01 |
Ā Former | 290(34.98) | 214(25.58) | 176(22.20) | 131(20.96) | Ā |
Ā Never | 507(56.54) | 559(63.23) | 613(67.83) | 657(69.07) | Ā |
Ā Now | 101(8.48) | 122(11.19) | 106(9.97) | 109(9.97) | Ā |
Drinking, n (%) | Ā | Ā | Ā | Ā | 0.19 |
Ā Mild | 569(64.02) | 528(60.79) | 509(60.99) | 497(55.59) | Ā |
Ā Moderate | 220(26.15) | 224(28.20) | 264(29.50) | 289(35.09) | Ā |
Ā Never | 109(9.83) | 143(11.00) | 122(9.52) | 111(9.33) | Ā |
Albumin (g/L) | 40.28(0.18) | 41.04(0.19) | 41.13(0.19) | 42.40(0.15) | ā<ā0.0001 |
ALT (U/L) | 25.58(0.73) | 23.10(0.61) | 23.60(0.65) | 16.87(0.35) | ā<ā0.0001 |
AST (U/L) | 22.32(0.48) | 21.66(0.51) | 21.26(0.37) | 20.05(0.47) | 0.01 |
GGT (U/L) | 36.88(1.95) | 29.64(1.34) | 26.93(1.24) | 18.37(0.53) | ā<ā0.0001 |
ALP (U/L) | 80.25(1.35) | 77.33(1.00) | 74.93(1.11) | 64.91(0.99) | ā<ā0.0001 |
HDL (mg/dL) | 47.63(0.64) | 55.12(0.74) | 52.61(0.44) | 60.52(0.84) | ā<ā0.0001 |
Triglycerides (mg/dL) | 179.15(6.61) | 140.90(3.12) | 140.79(4.59) | 95.05(2.47) | <ā0.0001 |
Total cholesterol (mg/dL) | 186.69(2.60) | 193.23(2.23) | 194.84(2.34) | 182.05(2.65) | 0.004 |
Waist circumference (cm) | 117.96(0.77) | 102.97(0.70) | 101.42(0.41) | 82.80(0.44) | ā<ā0.0001 |
Total bilirubin (umol/L) | 7.96(0.22) | 7.94(0.17) | 8.13(0.29) | 8.70(0.38) | 0.31 |
Creatinine (umol/L) | 80.91(1.05) | 78.30(1.17) | 76.38(0.76) | 72.22(0.60) | <ā0.0001 |
Uric acid (umol/L) | 351.67(4.21) | 329.60(4.57) | 317.00(3.38) | 279.38(3.34) | ā<ā0.0001 |
LSM (kpa) | 7.54(0.28) | 5.78(0.25) | 5.10(0.20) | 4.62(0.08) | <ā0.0001 |
CAP (db/m) | 314.77(3.00) | 273.12(2.99) | 263.58(2.97) | 214.78(2.34) | ā<ā0.0001 |
AIP | 1.20(0.04) | 0.85(0.02) | 0.87(0.03) | 0.36(0.02) | ā<ā0.0001 |
Using sex hormones, n (%) | Ā | Ā | Ā | 0.09 | |
Ā No | 872(96.00) | 867(94.76) | 845(92.30) | 833(91.85) | Ā |
Ā Yes | 26(4.00) | 28(5.24) | 50(7.70) | 64(8.15) | Ā |
Using antidepressants, n (%) | Ā | Ā | Ā | Ā | <ā0.001 |
Ā No | 739(81.87) | 801(86.18) | 811(87.54) | 847(92.84) | Ā |
Ā Yes | 159(18.13) | 94(13.82) | 84(12.46) | 50(7.16) | Ā |
Using steroid medications, n (%) | Ā | Ā | Ā | Ā | 0.27 |
Ā No | 871(97.93) | 873(97.72) | 881(97.27) | 884(98.94) | Ā |
Ā Yes | 27(2.07) | 22(2.28) | 14(2.73) | 13(1.06) | Ā |
MAFLD, n (%) | Ā | Ā | Ā | Ā | <ā0.0001 |
Ā No | 128(10.62) | 351(35.63) | 341(41.42) | 763(87.96) | Ā |
Ā Yes | 770(89.38) | 544(64.37) | 554(58.58) | 134(12.04) | Ā |